All stock lists
Solventum Corp (SOLV)
NYSE: SOLV · Real-Time Price · USD
Healthcare · Medical Instruments & Supplies
$85.80-$0.68 (-0.79%)
Insider Score
––Not scored
SOLV Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
Congress Trading
Recent trades of SOLV by members of U.S. Congress
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 27, 2026 |
| French HillHouse / R | Sale$15.00K – $50.00K | Dec 31, 2025 |
| Julie JohnsonHouse / D | Sale$1.00K – $15.00K | Jan 15, 2025 |
| Gary C. PetersSenate / D | Sale$1.00K – $15.00K | May 14, 2024 |
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
SOLV Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New SOLV patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to SOLV from public contracts
Source: USAspending.gov
Recently reported changes in SOLV holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing SOLV, reported under the STOCK Act.
Filters
| Senate | Buy | $1.00K – $15.00K | Mar 27, 2026 | |
| House | Sell | $15.00K – $50.00K | Dec 31, 2025 | |
| House | Sell | $1.00K – $15.00K | Jan 15, 2025 | |
| Senate | Sell | $1.00K – $15.00K | May 14, 2024 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
